Search Results - "Poulot, Virginie"

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures by DIEU-NOSJEAN, Marie-Caroline, ANTOINE, Martine, LEBECQUE, Serge, FRIDMAN, Wolf-Herman, CADRANEL, Jacques, DANEL, Claire, HEUDES, Didier, WISLEZ, Marie, POULOT, Virginie, RABBE, Nathalie, LAURANS, Ludivine, TARTOUR, Eric, DE CHAISEMARTIN, Luc

“…It has been established that the immune system plays an important role in tumor rejection. There is also compelling evidence that immune responses can develop…”
Get full text

Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung by Vieira, Thibault, Antoine, Martine, Ruppert, Anne-Marie, Fallet, Vincent, Duruisseaux, Michael, Giroux Leprieur, Etienne, Poulot, Virginie, Rabbe, Nathalie, Sclick, Laurene, Beau-Faller, Michele, Lacave, Roger, Lavole, Armelle, Cadranel, Jacques, Wislez, Marie

“…Highlights • A dedifferentiation process in NSCLC could lead to sarcomatoid carcinoma (SC). • NSCLC and SC share morphological, immunohistochemical and…”
Get full text

Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers by Michaël, Duruisseaux, Martine, Antoine, Nathalie, Rabbe, Anita, Rodenas, Anne, Mc Leer-Florin, Roger, Lacave, Virginie, Poulot, Belinda, Duchêne, Isabelle, Van Seuningen, Jacques, Cadranel, Marie, Wislez

“…Highlights • The role of mucins expression in lepidic adenocarcinoma is not fully understood. • MUC1 is associated with lepidic predominant adenocarcinoma. •…”
Get full text

BRAF V600E detection in cytological thyroid samples: A key component of the decision tree for surgical treatment of papillary thyroid carcinoma by Collet, Jean-François, Lacave, Roger, Hugonin, Sylvain, Poulot, Virginie, Tassart, Marc, Fajac, Anne

“…Background Whether preoperative knowledge of the BRAF mutation status would help to determine the extent of surgery for thyroid nodules is still under…”
Get full text

Secondary resistance to erlotinib: acquired T790M mutation and small-cell lung cancer transformation in the same patient by Fallet, Vincent, Ruppert, Anne-Marie, Poulot, Virginie, Lacave, Roger, Belmont, Laure, Antoine, Martine, Cadranel, Jacques, Wislez, Marie, Lavolé, Armelle

Get more information

Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinoma by Duruisseaux, Michaël, Rabbe, Nathalie, Antoine, Martine, Vieira, Thibault, Poulot, Virginie, Cadranel, Jacques, Wislez, Marie

“…Invasive mucinous adenocarcinoma (IMA) is a mucinous variant of lepidic predominant lung adenocarcinoma (LPA) and associated with a worse prognosis. We…”
Get full text

Neutrophils Promote Aerogenous Spread of Lung Adenocarcinoma with Bronchioloalveolar Carcinoma Features by WISLEZ, Marie, ANTOINE, Martine, RABBE, Nathalie, GOUNANT, Valérie, POULOT, Virginie, LAVOLE, Armelle, FLEURY-FEITH, Jocelyne, CADRANEL, Jacques

“…Purpose: Adenocarcinoma with bronchioloalveolar carcinoma (BAC) features is a subtype of non–small cell lung cancers characterized by an intense inflammatory…”
Get full text

BRAF V600E detection in cytological thyroid samples: A key component of the decision tree for surgical treatment of papillary thyroid carcinoma: BRAF Mutation Detection in Thyroid Cytological Samples by Collet, Jean-François, Lacave, Roger, Hugonin, Sylvain, Poulot, Virginie, Tassart, Marc, Fajac, Anne

Get full text

Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib by Wislez, Marie, Antoine, Martine, Baudrin, Laurence, Poulot, Virginie, Neuville, Agnes, Pradere, Maryvonne, Longchampt, Elisabeth, Isaac-Sibille, Sylvie, Lebitasy, Marie-Paule, Cadranel, Jacques

“…Abstract There is no optimal established therapy for treating advanced or recurrent adenocarcinoma with bronchioloalveolar carcinoma features (ADC-BAC), and it…”
Get full text

Impact of systematic EGFR and KRAS mutation evaluation on progression-free survival and overall survival in patients with advanced non-small-cell lung cancer treated by erlotinib in a French prospective cohort (ERMETIC project--part 2) by Cadranel, Jacques, Mauguen, Audrey, Faller, Michele, Zalcman, Gérard, Buisine, Marie-Pierre, Westeel, Virginie, Longchampt, Elisabeth, Wislez, Marie, Coudert, Bruno, Daniel, Catherine, Chetaille, Bruno, Michiels, Stephane, Blons, Helene, Solassol, Jerome, De Fraipont, Florence, Foucher, Pascal, Urban, Thierry, Lacroix, Ludovic, Poulot, Virginie, Quoix, Elisabeth, Antoine, Martine, Danton, Guillaume, Morin, Franck, Chouaid, Christos, Pignon, Jean-Pierre

“…Epidermal growth factor and v-Ki-ras2 Kirsten ras sarcoma (KRAS) mutation status, although associated with EGFR- tyrosine kinase inhibitor (TKI) efficacy, has…”
Get more information

Is there a specific phenotype associated with the different subtypes of KRAS mutations in patients with advanced non-small-cell lung cancers? by Dumenil, Coraline, Vieira, Thibault, Rouleau, Etienne, Antoine, Martine, Duruisseaux, Michael, Poulot, Virginie, Lacave, Roger, Cadranel, Jacques, Massiani, Marie-Ange, Wislez, Marie

“…Highlights • There is heterogeneousness in the spectrum of KRAS mutations in NSCLC. • The transitions and transversions are the two main categories of KRAS…”
Get full text

NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma by Duruisseaux, Michaël, McLeer‐Florin, Anne, Antoine, Martine, Alavizadeh, Sanaz, Poulot, Virginie, Lacave, Roger, Rabbe, Nathalie, Cadranel, Jacques, Wislez, Marie

“…Invasive mucinous lung adenocarcinoma (IMA) is a rare subtype of lung adenocarcinoma with no effective treatment option in advanced disease. KRAS mutations…”
Get full text

EGFR and KRAS mutation status in non–small-cell lung cancer occurring in HIV-infected patients by Créquit, Perrine, Ruppert, Anne-Marie, Rozensztajn, Nathalie, Gounant, Valérie, Vieira, T, Poulot, Virginie, Antoine, Martine, Chouaid, Christos, Wislez, Marie, Cadranel, Jacques, Lavole, Armelle

“…Highlights • 63 tumor samples were analyzed for EGFR and KRAS mutation out of 73HIV-NSCLC. • EGFR mutations were identified in two patients (3.3%). •…”
Get full text

The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation by Duruisseaux, Michael, Antoine, Martine, Rabbe, Nathalie, Poulot, Virginie, Fleury-Feith, Jocelyne, Vieira, Thibault, Lavolé, Armelle, Cadranel, Jacques, Wislez, Marie

“…Abstract Objectives This study investigated the clinical and prognostic impact of intracytoplasmic mucin in lung adenocarcinoma with “pneumonic” radiological…”
Get full text

Subsequent brain metastasis responses to epidermal growth factor receptor tyrosine kinase inhibitors in a patient with non-small-cell lung cancer by Gounant, Valérie, Wislez, Marie, Poulot, Virginie, Khalil, Antoine, Lavole, Armelle, Cadranel, Jacques, Milleron, Bernard

“…Summary In response to the paper by Popat et al. “Recurrent responses to non-small-cell lung cancer brain metastases with erlotinib”, we wish to report a…”
Get full text

Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project--part 1) by Beau-Faller, Michèle, Degeorges, Armelle, Rolland, Estelle, Mounawar, Mounia, Antoine, Martine, Poulot, Virginie, Mauguen, Audrey, Barbu, Véronique, Coulet, Florence, Prétet, Jean-Luc, Bièche, Ivan, Blons, Hélène, Boyer, Jean-Christophe, Buisine, Marie-Pierre, de Fraipont, Florence, Lizard, Sarab, Olschwang, Sylviane, Saulnier, Patrick, Prunier-Mirebeau, Delphine, Richard, Nicolas, Danel, Claire, Brambilla, Elisabeth, Chouaid, Christos, Zalcman, Gérard, Hainaut, Pierre, Michiels, Stefan, Cadranel, Jacques

“…The Evaluation of the epidermal growth factor receptor (EGFR) Mutation status for the administration of EGFR-Tyrosine Kinase Inhibitors in non-small cell lung…”
Get more information

Abstract A10: Prognostic significance of CXCL10/CXCR3 overexpression in mucinous bronchioloalveolar carcinoma by Duruisseaux, Michael, Antoine, Martine, Rabbe, Nathalie, Poulot, Virginie, Leprieur, Etienne Giroux, Lavolé, Armelle, Cadranel, Jacques, Wislez, Marie

“…Introduction: The 2004 WHO Pathological classification distinguishes two cytological subtypes of bronchioloalveolar carcinoma (BAC): mucinous (M) and…”
Get full text

Clinicopathologic and molecular factors associated with early progressive disease after front-line platinum-doublet chemotherapy (CT) for advanced non-small cell lung cancer (NSCLC) by Giroux Leprieur, Etienne, Antoine, Martine, Vieira, Thibault, Duruisseaux, Michael, Poulot, Virginie, Rabbe, Nathalie, Belmont, Laure, Gounant, Valérie, Lavole, Armelle, Milleron, Bernard, Lacave, Roger, Cadranel, Jacques, Wislez, Marie

“…Abstract only e18075 Background: The majority of cases of NSCLC are diagnosed at an advanced stage and treated with a platinum-doublet CT. However, some…”
Get full text

Abstract 1343: Toll-like Receptor 9 (TLR9) stimulation results in a change in tumor macrophage infiltration associated with an anti tumor effect in a mouse model of lung adenocarcinoma induced by oncogenic K-ras by Rabbe, Nathalie, Belmont, Laure, Yu, Jing, Poulot, Virginie, Gounant, Valérie, Antoine, Martine, Kurie, Jonathan, Cadranel, Jacques, Wislez, Marie

“…Microenvironment and immune system contribute to tumor escape in cancer. Toll-like Receptor 9 (TLR9) stimulation with a CpG ODN (PF-3512676) was expected to…”
Get full text

101: Identification of differential pathways in mucinous and non-mucinous subtypes of lung adenocarcinoma suggested new therapeutic strategies by Amandine, Hurbin, Busser, Benoît, Brambilla, Elisabeth, Moro-Sibilot, Denis, Antoine, Martine, Poulot, Virginie, Coll, Jean-Luc, Wislez, Marie, Cadranel, Jacques, Hurbin, Amandine

Get full text